Literature DB >> 29407211

Evaluation of the inactivation of Venezuelan equine encephalitis virus by several common methods.

Edward I Patterson1, Kelsey L Warmbrod2, Donald H Bouyer2, Naomi L Forrester2.   

Abstract

Working with virological samples requires validated inactivation protocols for safe handling and disposal. Although many techniques exist to inactivate samples containing viruses, not all procedures have been properly validated or are compatible with subsequent assays. To aid in the development of inactivation protocols for Alphaviruses, and specifically Venezuelan equine encephalitis virus (VEEV), a variety of methods were evaluated for their ability to completely inactivate a high titer sample of the vaccine strain VEEV TC-83. The methods evaluated include reagents used in RNA extraction, fixation, treatment with a detergent, and heat inactivation. Most methods were successful at inactivating the sample; however, treatment with only Buffer AVL, SDS, and heat inactivation at 58 °C for one hour were not capable of complete inactivation of the virus in the sample. These results provide a substantial framework for identifying techniques that are safe for complete inactivation of Alphaviruses and to advise protocol implementation.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alphavirus; Venezuelan equine encephalitis virus; Virus inactivation

Mesh:

Substances:

Year:  2018        PMID: 29407211      PMCID: PMC5826796          DOI: 10.1016/j.jviromet.2018.01.009

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  17 in total

Review 1.  Solubilization of membranes by detergents.

Authors:  A Helenius; K Simons
Journal:  Biochim Biophys Acta       Date:  1975-03-25

2.  Virus inactivation by nucleic acid extraction reagents.

Authors:  Jamie A Blow; David J Dohm; Diane L Negley; Christopher N Mores
Journal:  J Virol Methods       Date:  2004-08       Impact factor: 2.014

3.  Preparation of inactivated vaccines against alphaviruses using Semliki Forest virus-white mouse as a model. II. Evaluation of formalin-inactivated vaccines treated with tri(n-butyl)phosphate and-or saponin and properties of the inactivated virus.

Authors:  M Mussgay; E Weiland
Journal:  Intervirology       Date:  1973       Impact factor: 1.763

4.  Immunofluorescence assay for human immunodeficiency virus antibody: investigation of cell fixation for virus inactivation and antigen preservation.

Authors:  M Fauvel; G Ozanne
Journal:  J Clin Microbiol       Date:  1989-08       Impact factor: 5.948

5.  Rescue of infectious classical swine fever and foot-and-mouth disease virus by RNA transfection and virus detection by RT-PCR after extended storage of samples in Trizol.

Authors:  M A Hofmann; B Thür; L Liu; M Gerber; P Stettler; C Moser; S Bossy
Journal:  J Virol Methods       Date:  2000-06       Impact factor: 2.014

6.  Validating the Inactivation Effectiveness of Chemicals on Ebola Virus.

Authors:  Elaine Haddock; Friederike Feldmann
Journal:  Methods Mol Biol       Date:  2017

7.  Thermal stability and inactivation of hepatitis C virus grown in cell culture.

Authors:  Hongshuo Song; Jin Li; Shuang Shi; Ling Yan; Hui Zhuang; Kui Li
Journal:  Virol J       Date:  2010-02-18       Impact factor: 4.099

8.  A broad-spectrum microbicide with virucidal activity against sexually transmitted viruses.

Authors:  M K Howett; E B Neely; N D Christensen; B Wigdahl; F C Krebs; D Malamud; S D Patrick; M D Pickel; P A Welsh; C A Reed; M G Ward; L R Budgeon; J W Kreider
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

9.  Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus.

Authors:  Mugdha Tiwari; Manmohan Parida; S R Santhosh; Mohsin Khan; Paban Kumar Dash; P V Lakshmana Rao
Journal:  Vaccine       Date:  2009-02-27       Impact factor: 3.641

10.  Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5'-noncoding region and the E2 envelope glycoprotein.

Authors:  R M Kinney; G J Chang; K R Tsuchiya; J M Sneider; J T Roehrig; T M Woodward; D W Trent
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

View more
  5 in total

1.  Inactivation of SARS-CoV-2 on surfaces and in solution with Virusend (TX-10), a novel disinfectant.

Authors:  Enyia R Anderson; Grant L Hughes; Edward I Patterson
Journal:  Access Microbiol       Date:  2021-04-26

2.  Methods of Inactivation of SARS-CoV-2 for Downstream Biological Assays.

Authors:  Edward I Patterson; Tessa Prince; Enyia R Anderson; Aitor Casas-Sanchez; Shirley L Smith; Cintia Cansado-Utrilla; Tom Solomon; Michael J Griffiths; Álvaro Acosta-Serrano; Lance Turtle; Grant L Hughes
Journal:  J Infect Dis       Date:  2020-10-01       Impact factor: 5.226

3.  Use of guanidine thiocyanate-based nucleic acid extraction buffers to inactivate poliovirus in potentially infectious materials.

Authors:  Michelle J Honeywood; Stacey Jeffries-Miles; Kimberly Wong; Chelsea Harrington; Cara C Burns; M Steven Oberste; Michael D Bowen; Everardo Vega
Journal:  J Virol Methods       Date:  2021-08-09       Impact factor: 2.623

4.  Heat inactivation of clinical COVID-19 samples on an industrial scale for low risk and efficient high-throughput qRT-PCR diagnostic testing.

Authors:  Oona Delpuech; Julie A Douthwaite; Thomas Hill; Dhevahi Niranjan; Nancy T Malintan; Hannah Duvoisin; Jane Elliott; Ian Goodfellow; Myra Hosmillo; Alexandra L Orton; Molly A Taylor; Christopher Brankin; Haidee Pitt; Douglas Ross-Thriepland; Magdalena Siek; Anna Cuthbert; Ian Richards; John R Ferdinand; Colin Barker; Robert Shaw; Cristina Ariani; Ian Waddell; Steve Rees; Clive Green; Roger Clark; Abhishek Upadhyay; Rob Howes
Journal:  Sci Rep       Date:  2022-02-21       Impact factor: 4.379

5.  Measuring Alphavirus Fidelity Using Non-Infectious Virus Particles.

Authors:  Edward I Patterson; Kamil Khanipov; Daniele M Swetnam; Samantha Walsdorf; Tiffany F Kautz; Saravanan Thangamani; Yuriy Fofanov; Naomi L Forrester
Journal:  Viruses       Date:  2020-05-15       Impact factor: 5.818

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.